QT
TERN

Quantbot Technologies’s Terns Pharmaceuticals TERN Stock Holding History

Quantbot Technologies’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.48M Buy
+47,043
New +$1.93M 0.1% 308
2024
Q4 		– Sell
-120,838
Closed -$1.01M – 1823
2024
Q3 		$1.01M Buy
120,838
+117,079
+3,115% +$963K 0.04% 620
2024
Q2 		$25.6K Buy
+3,759
New +$22.8K ﹤0.01% 1315
2024
Q1 		– Sell
-4,498
Closed -$29.2K – 1939
2023
Q4 		$29.2K Buy
4,498
+2,198
+96% +$11.6K ﹤0.01% 1400
2023
Q3 		$11.6K Buy
+2,300
New +$14.6K ﹤0.01% 1396

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Quantbot Technologies's TERN Position: Q1 2026 in Review

Quantbot Technologies opened a new position in Terns Pharmaceuticals (TERN) in Q1 2026: 47,043 shares worth $2.48M. The stake represents 0.1% of the portfolio and ranks #308 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in TERN as recently as Q3 2024.

Quantbot Technologies first reported a position in TERN in Q3 2023 and has held it in 5 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Quantbot Technologies held 47,043 shares of Terns Pharmaceuticals worth $2.48M as of Q1 2026.
  • Terns Pharmaceuticals was a new Quantbot Technologies position in Q1 2026.
  • Terns Pharmaceuticals made up 0.1% of Quantbot Technologies's portfolio in Q1 2026, its #308 holding.
  • Quantbot Technologies first reported a position in Terns Pharmaceuticals in Q3 2023 and has held it in 5 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.